RESUMEN
Acute respiratory distress syndrome (ARDS) is a common cause of critical illness and high mortality from respiratory failure. Increased dead space fraction (VD/VT) was independently associated with lung injury and mortality of ARDS. VD/VT is readily obtained by bedside measurements of arterial blood gas and end-tidal carbon dioxide. Early attention and application of VD/VT as an indicator will help to better understand the pathophysiological of ARDS, guide clinical treatment, and better assess the severity and clinical prognosis of the disease.
Asunto(s)
Lesión Pulmonar , Síndrome de Dificultad Respiratoria , Humanos , Espacio Muerto Respiratorio/fisiología , Síndrome de Dificultad Respiratoria/diagnóstico , Síndrome de Dificultad Respiratoria/terapia , Pronóstico , Dióxido de Carbono , Volumen de Ventilación Pulmonar/fisiologíaAsunto(s)
COVID-19 , Neumonía , Humanos , Pulmón , Espacio Muerto Respiratorio , Fenómenos Fisiológicos RespiratoriosRESUMEN
Cumulative evidence has demonstrated that the ventilatory ratio closely correlates with mortality in acute respiratory distress syndrome (ARDS), and a primary feature in coronavirus disease 2019 (COVID-19)-ARDS is increased dead space that has been reported recently. Thus, new attention has been given to this group of dead space ventilation-related indices, such as physiological dead space fraction, ventilatory ratio, and end-tidal-to-arterial PCO2 ratio, which, albeit distinctive, are all global indices with which to assess the relationship between ventilation and perfusion. These parameters have already been applied to positive end expiratory pressure titration, prediction of responses to the prone position and the field of extracorporeal life support for patients suffering from ARDS. Dead space ventilation-related indices remain hampered by several deflects; notwithstanding, for this catastrophic syndrome, they may facilitate better stratifications and identifications of subphenotypes, thereby providing therapy tailored to individual needs.
Asunto(s)
COVID-19 , Síndrome de Dificultad Respiratoria , Humanos , Pulmón , Respiración con Presión Positiva , Síndrome de Dificultad Respiratoria/terapia , Perfusión , Espacio Muerto Respiratorio/fisiología , Volumen de Ventilación Pulmonar , Respiración ArtificialAsunto(s)
COVID-19 , Neumonía , Humanos , Pulmón , Espacio Muerto Respiratorio , Fenómenos Fisiológicos RespiratoriosRESUMEN
PURPOSE: To determine whether VDPhys/VT is associated with coagulation activation and outcomes. MATERIALS AND METHODS: We enrolled patients with COVID-19 pneumonia who were supported by invasive mechanical ventilation and were monitored using volumetric capnography. Measurements were performed during the first 24 h of mechanical ventilation. The primary endpoint was the likelihood of being discharge alive on day 28. RESULTS: Sixty patients were enrolled, of which 25 (42%) had high VDPhys/VT (>57%). Patients with high vs. low VDPhys/VT had higher APACHE II (10[8-13] vs. 8[6-9] points, p = 0.002), lower static compliance of the respiratory system (35[24-46] mL/cmH2O vs. 42[37-45] mL/cmH2O, p = 0.005), and higher D-dimer levels (1246[1050-1594] ng FEU/mL vs. 792[538-1159] ng FEU/mL, p = 0.001), without differences in P/F ratio (157[112-226] vs. 168[136-226], p = 0.719). Additionally, D-dimer levels correlated with VDPhys/VT (r = 0.530, p < 0.001), but not with the P/F ratio (r = -0.103, p = 0.433). Patients with high VDPhys/VT were less likely to be discharged alive on day 28 (32% vs. 71%, aHR = 3.393[1.161-9.915], p = 0.026). CONCLUSIONS: In critically ill COVID-19 patients, increased VDPhys/VT was associated with high D-dimer levels and a lower likelihood of being discharged alive. Dichotomic VDPhys/VT could help identify a high-risk subgroup of patients neglected by the P/F ratio.
Asunto(s)
COVID-19 , Síndrome de Dificultad Respiratoria , COVID-19/terapia , Capnografía , Humanos , Respiración Artificial , Espacio Muerto Respiratorio/fisiología , Síndrome de Dificultad Respiratoria/terapia , Volumen de Ventilación Pulmonar/fisiologíaAsunto(s)
Betacoronavirus/fisiología , Infecciones por Coronavirus/clasificación , Hipoxia/fisiopatología , Rendimiento Pulmonar/fisiología , Pulmón/fisiopatología , Pandemias/clasificación , Neumonía Viral/clasificación , Resistencia de las Vías Respiratorias , COVID-19 , Comorbilidad , Infecciones por Coronavirus/fisiopatología , Infecciones por Coronavirus/terapia , Guías como Asunto , Humanos , Hipoxia/diagnóstico por imagen , Hipoxia/virología , Pulmón/diagnóstico por imagen , Pulmón/virología , Tamaño de los Órganos , Fenotipo , Neumonía Viral/fisiopatología , Neumonía Viral/terapia , Radiografía Torácica , Espacio Muerto Respiratorio , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Relación Ventilacion-PerfusiónAsunto(s)
COVID-19/terapia , Milrinona/uso terapéutico , Terapia por Inhalación de Oxígeno/métodos , Respiración Artificial/métodos , Vasodilatadores/uso terapéutico , Administración por Inhalación , Anciano , Femenino , Humanos , Hipertensión Pulmonar , Masculino , Persona de Mediana Edad , Milrinona/administración & dosificación , Espacio Muerto Respiratorio , Vasodilatadores/administración & dosificaciónRESUMEN
BACKGROUND: Estimates for dead space ventilation have been shown to be independently associated with an increased risk of mortality in the acute respiratory distress syndrome and small case series of COVID-19-related ARDS. METHODS: Secondary analysis from the PRoVENT-COVID study. The PRoVENT-COVID is a national, multicenter, retrospective observational study done at 22 intensive care units in the Netherlands. Consecutive patients aged at least 18 years were eligible for participation if they had received invasive ventilation for COVID-19 at a participating ICU during the first month of the national outbreak in the Netherlands. The aim was to quantify the dynamics and determine the prognostic value of surrogate markers of wasted ventilation in patients with COVID-19-related ARDS. RESULTS: A total of 927 consecutive patients admitted with COVID-19-related ARDS were included in this study. Estimations of wasted ventilation such as the estimated dead space fraction (by Harris-Benedict and direct method) and ventilatory ratio were significantly higher in non-survivors than survivors at baseline and during the following days of mechanical ventilation (p < 0.001). The end-tidal-to-arterial PCO2 ratio was lower in non-survivors than in survivors (p < 0.001). As ARDS severity increased, mortality increased with successive tertiles of dead space fraction by Harris-Benedict and by direct estimation, and with an increase in the VR. The same trend was observed with decreased levels in the tertiles for the end-tidal-to-arterial PCO2 ratio. After adjustment for a base risk model that included chronic comorbidities and ventilation- and oxygenation-parameters, none of the dead space estimates measured at the start of ventilation or the following days were significantly associated with 28-day mortality. CONCLUSIONS: There is significant impairment of ventilation in the early course of COVID-19-related ARDS but quantification of this impairment does not add prognostic information when added to a baseline risk model. TRIAL REGISTRATION: ISRCTN04346342. Registered 15 April 2020. Retrospectively registered.
Asunto(s)
COVID-19/mortalidad , Gravedad del Paciente , Respiración Artificial , Espacio Muerto Respiratorio , Síndrome de Dificultad Respiratoria/terapia , Adulto , Biomarcadores , COVID-19/complicaciones , COVID-19/fisiopatología , Femenino , Humanos , Unidades de Cuidados Intensivos , Masculino , Pronóstico , Curva ROC , Síndrome de Dificultad Respiratoria/etiología , Pruebas de Función Respiratoria , Mecánica Respiratoria , Estudios RetrospectivosRESUMEN
During the recent CoVID-19 pandemic, airway management recommendations have been provided to decrease aerosolization and risk of viral spread to healthcare providers. High efficiency particulate air (HEPA) viral filters and adaptors are one way to decrease the risk of aerosolization during intubation. When placed proximal to the ventilator circuit, these viral filters and adaptors can create a significant amount of dead space, which in our smallest patients can significantly impact effective ventilation. We report a case of hypoventilation in a pediatric patient due to lack of provider team appreciation or ventilator sensing of additional dead space due to HEPA viral filter and adaptor.
Asunto(s)
Acidosis Respiratoria/etiología , Filtros de Aire/efectos adversos , Manejo de la Vía Aérea/efectos adversos , COVID-19/prevención & control , Hipercapnia/etiología , Enfermedad Aguda , COVID-19/transmisión , Humanos , Lactante , Espacio Muerto RespiratorioAsunto(s)
Betacoronavirus , Infecciones por Coronavirus/complicaciones , Neumonía Viral/complicaciones , Insuficiencia Respiratoria/complicaciones , COVID-19 , Infecciones por Coronavirus/fisiopatología , Femenino , Humanos , Unidades de Cuidados Intensivos , Londres , Masculino , Persona de Mediana Edad , Pandemias , Neumonía Viral/fisiopatología , Respiración Artificial , Espacio Muerto Respiratorio , Insuficiencia Respiratoria/fisiopatología , Insuficiencia Respiratoria/terapia , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Medicina EstatalRESUMEN
BACKGROUND: The ratio of end-tidal CO2 pressure to arterial partial pressure of CO2 ([Formula: see text]) was recently suggested for monitoring pulmonary gas exchange in patients with ARDS associated with COVID-19, yet no evidence was offered supporting that claim. Therefore, we evaluated whether [Formula: see text] might be relevant in assessing ARDS not associated with COVID-19. METHODS: We evaluated the correspondence between [Formula: see text] and the ratio of dead space to tidal volume (VD/VT) measured in 561 subjects with ARDS from a previous study in whom [Formula: see text] data were also available. Subjects also were analyzed according to 4 ranges of [Formula: see text] representing increasing illness severity (≥ 0.80, 0.6-0.79, 0.50-0.59, and < 0.50). Correlation was assessed by either Pearson or Spearman tests, grouped comparisons were assessed using either ANOVA or Kruskal-Wallis tests and dichotomous variables assessed by Fisher Exact tests. Normally distributed data are presented as mean and standard deviation(SD) and non-normal data are presented as median and inter-quartile range (IQR). Overall mortality risk was assessed with multivariate logistic regression. Alpha was set at 0.05. RESULTS: [Formula: see text] correlated strongly with VD/VT (r = -0.87 [95% CI -0.89 to -0.85], P < .001). Decreasing [Formula: see text] was associated with increased VD/VT and hospital mortality between all groups. In the univariate analysis, for every 0.01 decrease in [Formula: see text], mortality risk increased by â¼1% (odds ratio 0.009, 95% CI 0.003-0.029, P < .001) and maintained a strong independent association with mortality risk when adjusted for other variables (odds ratio 0.19, 95% CI 0.04-0.91, P = .039). [Formula: see text] < 0.50 was characterized by very high mean ± SD value for VD/VT (0.82 ± 0.05, P < .001) and high hospital mortality (70%). CONCLUSIONS: Using [Formula: see text] as a surrogate for VD/VT may be a useful and practical measurement for both management and ongoing research into the nature of ARDS.